GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GRAL GRAIL, Inc.

交易中 08-17 15:37:24 EDT

70.26

+2.39

+3.52%

最高71.20	最低67.00	成交量49.86万
今开67.33	昨收67.87	日振幅6.18%
总市值31.38亿	流通市值28.56亿	总股本4,467万
成交额3,497万	换手率1.23%	流通股本4,064万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":70.26,"timestamp":1786995440198,"preClose":67.87,"halted":0,"volume":498634,"delay":0,"changeRate":0.035214380433181085,"floatShares":40644723,"shares":44666200,"eps":-9.748709,"marketStatus":"交易中","change":2.39,"latestTime":"08-17 15:37:24 EDT","open":67.33,"high":71.195,"low":67,"amount":34974737.2574,"amplitude":0.061809,"askPrice":70.5,"askSize":208,"bidPrice":70.35,"bidSize":420,"shortable":3,"etf":0,"ttmEps":-9.748709,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786996800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":67.87,"preHourTrading":{"tag":"盘前","latestPrice":67.86,"preClose":67.87,"latestTime":"09:29 EDT","volume":72,"amount":4942.609920000001,"timestamp":1786973341059,"change":-0.01,"changeRate":-0.000147,"amplitude":0.016797},"postHourTrading":{"tag":"盘后","latestPrice":67.87,"preClose":67.87,"latestTime":"19:47 EDT","volume":15207,"amount":1032121.33,"timestamp":1786751265560,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.755243,"impliedVol":0.7443,"impliedVolPercentile":0.0279},"requestUrl":"/m/hq/s/GRAL","defaultTab":"news","newsList":[{"id":"1180134132","title":"GRAIL宣布FDA咨询委员会会议将审议Galleri®多癌早检上市前申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1180134132","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180134132?lang=zh_cn&edition=full","pubTime":"2026-08-07 23:06","pubTimestamp":1786115182,"startTime":"0","endTime":"0","summary":"GRAIL（股票代码：GRAL）正式对外披露，美国食品药品监督管理局（FDA）已计划召开一场咨询委员会会议，专门针对其旗下面向多癌种早期检测的Galleri®检测产品，所提交的上市前批准申请（PMA）进行深入审议。这一里程碑式的进展，标志着该潜在颠覆性癌症筛查技术，在通往监管绿灯的道路上，迈出了至关重要的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191676874","title":"Priority Health携手GRAIL，成为密歇根州首个为雇主计划提供Galleri®多癌种早期检测血液测试的医疗计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1191676874","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191676874?lang=zh_cn&edition=full","pubTime":"2026-07-16 21:01","pubTimestamp":1784206891,"startTime":"0","endTime":"0","summary":"Priority Health与GRAIL, Inc.达成合作，开创密歇根州先河，成为该州首个将Galleri®多癌种早期检测血液测试纳入雇主医疗计划的健康保险机构。此项合作旨在通过前沿的液体活检技术，为参保员工提供更早发现多种癌症的机会，从而可能改善治疗结果并降低医疗成本。Galleri®测试能够通过单次抽血，筛查出50多种癌症的信号，其中包括许多缺乏常规筛查指南的癌症类型。这一举措标志着精准医疗和预防性健康管理在雇主福利领域的重要拓展，有望提升整体人群的健康水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104190016","title":"GRAIL在2026年ASCO年会上公布NHS-Galleri试验完整结果，显示晚期癌症诊断数量显著减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1104190016","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104190016?lang=zh_cn&edition=full","pubTime":"2026-05-30 20:01","pubTimestamp":1780142464,"startTime":"0","endTime":"0","summary":"GRAIL公司在2026年美国临床肿瘤学会（ASCO）年会上，正式公布了其NHS-Galleri试验的完整数据。该试验结果明确显示，通过其多癌种早期检测血液检测技术Galleri，能够显著降低第四期（晚期）癌症的诊断数量。这一关键数据进一步验证了该检测方法在癌症早期发现与干预方面的潜在价值，为改善癌症患者预后提供了新的有力证据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142483101","title":"财报前瞻｜GRAIL, Inc.本季度营收预计小幅增长，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1142483101","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142483101?lang=zh_cn&edition=full","pubTime":"2026-04-29 00:55","pubTimestamp":1777395357,"startTime":"0","endTime":"0","summary":"GRAIL, Inc.将于2026年05月05日美股盘后发布最新季度财报，市场关注收入增速能否延续、费用投放节奏与利润率改善。市场目前一致预期本季度GRAIL, Inc.营收为3,888.14万美元，同比增长10.46%；息税前亏损为1.26亿美元，同比增长11.44%；调整后每股收益为-2.76美元，同比增长32.45%。从近期针对GRAIL, Inc.的研究报道中，机构观点偏谨慎，关注点集中在收入增速放缓与费用投入的回报周期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜GRAIL, Inc.本季度营收预计小幅增长，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618819906","title":"Grail, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618819906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618819906?lang=zh_cn&edition=full","pubTime":"2026-03-11 23:29","pubTimestamp":1773242953,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日23时29分，Grail, Inc.股票出现异动，股价大幅下跌5.01%。截至发稿，该股报46.23美元/股，成交量26.3417万股，换手率0.65%，振幅4.83%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.79%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 、Xwell, Inc.、Prenetics Global涨幅较大，Mainz Biomed N.V.、Xwell, Inc.、Bioaffinity Technologies, Inc.较为活跃，换手率分别为38.81%、10.07%、7.91%，振幅较大的相关个股有Xwell, Inc.、Inotiv, Inc.、Prenetics Global，振幅分别为17.14%、16.50%、12.29%。Grail, Inc.公司简介：GRAIL Inc 是一家专注于开发早期癌症检测技术的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311232913a461a2a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311232913a461a2a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612298036","title":"Grail公司的多癌检测测试未达目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2612298036","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2612298036?lang=zh_cn&edition=full","pubTime":"2026-02-20 23:12","pubTimestamp":1771600320,"startTime":"0","endTime":"0","summary":"专注于开发基于血液检测的癌症筛查技术的生物科技公司Grail公司（GRAL）的 Galleri 检测在一项大型英国国家医疗服务体系研究中未能达到主要终点，这对早期多癌检测血液检测来说是一个挫折；该公司报告称2025年售出了185000次检测。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-20/doc-inhnnssa5719078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147942002","title":"Grail盘前暴跌47%，罪魁祸首是这些检测结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1147942002","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147942002?lang=zh_cn&edition=full","pubTime":"2026-02-20 17:32","pubTimestamp":1771579965,"startTime":"0","endTime":"0","summary":"生物科技公司Grail盘前交易中股价暴跌47%，此前该公司癌症试验结果令投资者失望。Galleri是一种由Grail开发的血液检测，用于在癌症出现症状前筛查多种癌症。收盘后股价暴跌48%至52.25美元；截至周四收盘，该股在过去六个月已上涨逾200%。Grail于1月向美国食品药品监督管理局提交了上市前批准申请。公司补充称，提交材料中包含了NHS试验第一年的结果。Grail第四季度每股亏损2.44美元，好于预期；营收4360万美元，与华尔街预估基本一致。","market":"us","thumbnail":"https://static.tigerbbs.com/516cbe31098a2a42f16da93a5544fbb1","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/516cbe31098a2a42f16da93a5544fbb1"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1152034500","title":"异动解读 | 第四季度财报亏损且核心癌症测试未达目标，GRAIL公司盘前大跌47.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152034500","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152034500?lang=zh_cn&edition=full","pubTime":"2026-02-20 17:11","pubTimestamp":1771578683,"startTime":"0","endTime":"0","summary":"GRAIL公司(GRAL)今日盘前股价大跌47.5%，引发了市场的广泛关注。消息面上，公司发布的第四季度财报显示净亏损为9920万美元，较上一季度有所增加。同时，公司宣布其关键的多种癌症早期检测试验Galleri未能达到在统计学上显著降低晚期癌症诊断率的主要研究目标，尽管在部分致命癌症中观察到了积极趋势。这一双重负面消息严重打击了投资者信心。Galleri测试是GRAIL公司的核心产品，其临床试验结果未达主要终点，引发了市场对公司未来增长前景和产品商业化潜力的深度担忧，直接导致了股价在盘前交易时段的大幅下挫。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188289893","title":"异动解读 | 第四季度财报亏损且癌症测试未达目标，GRAIL公司夜盘大跌47.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188289893","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188289893?lang=zh_cn&edition=full","pubTime":"2026-02-20 09:04","pubTimestamp":1771549446,"startTime":"0","endTime":"0","summary":"GRAIL公司(GRAL)今日夜盘股价大跌47.49%，引发了市场的广泛关注。消息面上，公司发布了第四季度财报，显示净亏损为9920万美元，较上一季度有所增加。同时，公司宣布其关键的多种癌症早期检测试验Galleri未能达到在统计学上显著降低晚期癌症诊断率的主要研究目标，尽管在部分致命癌症中观察到了积极趋势。这一双重负面消息严重打击了投资者信心。Galleri测试是GRAIL公司的核心产品，其临床试验结果未达主要终点，引发了市场对公司未来增长前景和产品商业化潜力的深度担忧，直接导致了股价在夜盘交易时段的大幅下挫。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158231115","title":"异动解读 | 第四季度财报亏损且癌症测试未达目标，GRAIL公司盘后大跌33.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158231115","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158231115?lang=zh_cn&edition=full","pubTime":"2026-02-20 05:47","pubTimestamp":1771537653,"startTime":"0","endTime":"0","summary":"GRAIL公司(GRAL)今日盘后股价大跌33.22%，引发了市场的广泛关注。消息面上，公司发布了第四季度财报，显示净亏损为9920万美元，较上一季度有所增加。同时，公司宣布其关键的多种癌症早期检测试验Galleri未能达到在统计学上显著降低晚期癌症诊断率的主要研究目标，尽管在部分致命癌症中观察到了积极趋势。这一双重负面消息严重打击了投资者信心。Galleri测试是GRAIL公司的核心产品，其临床试验结果未达主要终点，引发了市场对公司未来增长前景和产品商业化潜力的担忧，直接导致了股价在盘后交易时段的大幅下挫。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127672767","title":"里程碑式NHS-Galleri试验显示：IV期癌症诊断大幅减少，I/II期致命癌症检出率提升，癌症总体检出率激增四倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1127672767","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127672767?lang=zh_cn&edition=full","pubTime":"2026-02-20 05:02","pubTimestamp":1771534933,"startTime":"0","endTime":"0","summary":"具有里程碑意义的NHS-Galleri试验取得突破性成果。数据显示，该检测方法显著降低了IV期癌症的诊断比例。同时，针对致命性癌症的早期筛查能力大幅提升——I期和II期癌症检出率明显增加。更令人瞩目的是，整体癌症检测灵敏度达到常规方法的四倍以上。这项突破为癌症早筛领域带来全新可能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518022743","title":"Grail, Inc.盘中异动 急速跳水5.38%报31.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518022743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518022743?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613489,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Grail, Inc.股票出现异动，股价快速下跌5.38%。截至发稿，该股报31.11美元/股，成交量2.6055万股，换手率0.08%，振幅0.94%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.54%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213129a26a246b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213129a26a246b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517613371","title":"Grail, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517613371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517613371?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:38","pubTimestamp":1741271897,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时38分，Grail, Inc.股票出现异动，股价快速下挫5.08%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.78%。其相关个股中，Fulgent Genetics, Inc.、安奈特保险、Bioaffinity Technologies, Inc.涨幅较大，Mainz Biomed N.V.、Endra Life Sciences Inc.、Ispecimen Inc.较为活跃，换手率分别为0.60%、0.47%、0.42%，振幅较大的相关个股有Bioaffinity Technologies, Inc.、Biodesix, Inc.、Check-Cap Ltd.，振幅分别为15.27%、10.31%、8.96%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223818963c4e79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223818963c4e79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517946610","title":"Grail, Inc.盘中异动 快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517946610?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:38","pubTimestamp":1741189101,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时38分，Grail, Inc.股票出现波动，股价急速上涨5.12%。截至发稿，该股报43.66美元/股，成交量32.5545万股，换手率0.96%，振幅7.10%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.49%。其相关个股中，Neuronetics, Inc.、Oncocyte Corporation、Biodesix, Inc.涨幅较大，Neuronetics, Inc.、Ispecimen Inc.、Grail, Inc.较为活跃，换手率分别为2.12%、1.99%、0.98%，振幅较大的相关个股有Bioaffinity Technologies, Inc.、Neuronetics, Inc.、Oncocyte Corporation，振幅分别为17.70%、16.55%、15.98%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233821989d56b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233821989d56b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516967735","title":"Grail, Inc.盘中异动 早盘急速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516967735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516967735?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:31","pubTimestamp":1741098671,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分，Grail, Inc.股票出现异动，股价大幅下跌5.03%。截至发稿，该股报34.50美元/股，成交量2.064万股，换手率0.06%，振幅0.00%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.05%。其相关个股中，Prenetics Global、Mainz Biomed N.V.、Neuronetics, Inc.涨幅较大，Biodesix, Inc.、Ispecimen Inc.、Natera, Inc.较为活跃，换手率分别为2.00%、0.77%、0.66%，振幅较大的相关个股有Xwell, Inc.、Mdxhealth Sa、Applied Dna Sciences, Inc.，振幅分别为3.25%、2.92%、1.44%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223111a25f03ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223111a25f03ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514335555","title":"Grail, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514335555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514335555?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:51","pubTimestamp":1740678661,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时51分，Grail, Inc.股票出现波动，股价急速下跌5.03%。截至发稿，该股报41.66美元/股，成交量44.1125万股，换手率1.30%，振幅9.53%。Grail, Inc.股票所在的生命科学行业中，整体跌幅为0.96%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228015101abdf9c65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228015101abdf9c65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514859066","title":"Grail, Inc.盘中异动 大幅上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514859066?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:59","pubTimestamp":1740581955,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时59分，Grail, Inc.股票出现异动，股价大幅上涨5.36%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.06%。其相关个股中，Neuronetics, Inc.、Bioaffinity Technologies Inc C/Wts 07/09/2027 、Guardant Health, Inc.涨幅较大，Prophase Labs, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃，换手率分别为6.26%、2.70%、1.77%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Prophase Labs, Inc.、Bioaffinity Technologies, Inc.，振幅分别为14.68%、13.69%、9.23%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225915963154cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225915963154cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513722748","title":"Grail, Inc.盘中异动 早盘股价大涨5.16%报42.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513722748?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:34","pubTimestamp":1740407655,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时34分，Grail, Inc.股票出现波动，股价快速拉升5.16%。截至发稿，该股报42.83美元/股，成交量9.387万股，换手率0.28%，振幅9.18%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.50%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223415abdb0e67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223415abdb0e67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513756136","title":"Grail, Inc.2024财年实现净利润-20.27亿美元，同比减少38.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513756136?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326472,"startTime":"0","endTime":"0","summary":"2月24日，Grail, Inc.公布财报，公告显示公司2024财年净利润为-20.27亿美元，同比减少38.27%；其中营业收入为1.26亿美元，同比增加35.32%，每股基本收益为-63.54美元。从资产负债表来看，Grail, Inc.总负债4.80亿美元，其中短期债务13.26百万美元，资产负债比为6.22，流动比率为0.11。机构评级：截至2025年2月24日，当前有1家机构对Grail, Inc.目标价做出预测，其中目标均价为16.00美元，其中最低目标价为16.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000143a250ce17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000143a250ce17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513296599","title":"Grail, Inc.盘中异动 早盘股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513296599?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148287,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Grail, Inc.股票出现波动，股价急速跳水5.47%。Grail, Inc.股票所在的生命科学行业中，整体涨幅为0.17%。其相关个股中，Atlantic International Corp.、Prophase Labs, Inc.、安奈特保险涨幅较大，Prophase Labs, Inc.、Mainz Biomed N.V.、Precipio, Inc.较为活跃，换手率分别为6.96%、0.94%、0.28%，振幅较大的相关个股有Grail, Inc.、Neuronetics, Inc.、Prophase Labs, Inc.，振幅分别为7.54%、5.25%、4.88%。Grail, Inc.公司简介：GRAIL Inc是一家医疗保健公司，致力于开发用于早期癌症检测的技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223127962b7b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223127962b7b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://grail.com;investors.grail.com","stockEarnings":[{"period":"1week","weight":-0.0232},{"period":"1month","weight":-0.0873},{"period":"3month","weight":0.1378},{"period":"6month","weight":-0.3039},{"period":"1year","weight":1.1091},{"period":"ytd","weight":-0.207}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0503},{"period":"6month","weight":0.1387},{"period":"1year","weight":0.2037},{"period":"ytd","weight":0.1385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Grail, Inc.于2015年9月11日在特拉华州注册成立。该公司是一家医疗保健公司，致力于通过开创癌症早期检测的新技术来拯救生命和改善健康。该公司建立了一个由科学家、工程师和医生组成的多学科组织，它正利用下一代测序（NGS）、人群规模临床研究以及最先进的计算机科学和数据科学的力量来克服医学的最大挑战之一。该公司利用该公司的平台技术，开发了一种多癌症早期检测血液检测方法，在临床研究中证明了从一次抽血中就可以检测出50多种癌症类型，并能高度准确地定位癌症信号。","exchange":"NASDAQ","name":"GRAIL, Inc.","nameEN":"GRAIL, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GRAIL, Inc.(GRAL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GRAIL, Inc.,GRAL,GRAIL, Inc.股票,GRAIL, Inc.股票老虎,GRAIL, Inc.股票老虎国际,GRAIL, Inc.行情,GRAIL, Inc.股票行情,GRAIL, Inc.股价,GRAIL, Inc.股市,GRAIL, Inc.股票价格,GRAIL, Inc.股票交易,GRAIL, Inc.股票购买,GRAIL, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAIL, Inc.(GRAL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GRAIL, Inc.(GRAL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}